Search

everythinglearnresearchcommunity

for

Search:↓

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Lokivetmab reduced itching in a dog with skin lymphoma.

Biologics for severe asthma have known side effects, but some new risks need more study.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

GPCRs are vital for wound healing by affecting cell growth and immune response.

New therapies for rare skin diseases show promise but need more research.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Adalimumab can cause complete hair loss in rare cases.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Terbinafine can cause hair loss.

Some alternative therapies for vitiligo show promise but need more research.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Cyclosporin doesn't stop hair loss.

Polymeric nanoparticles show promise for treating skin diseases.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

DPP4 is important for scarring and skin regeneration, and managing its activity could improve skin healing treatments.

The study found that p63 needs signals from morphogens to help skin cells differentiate properly.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

PGD2 stops hair growth and is higher in bald men with AGA.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

PLD is an effective and safer alternative for treating breast cancer.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.